ARTICLE | Clinical News
Celgosivir: Phase II start
July 24, 2006 7:00 AM UTC
This month, MGI will start a Canadian Phase II trial in up to 20 treatment-naïve HCV patients. The trial will compare celgosivir plus peginterferon alfa-2b and ribavirin with peginterferon alfa-2b and...